Share of valid CEPs for API quality globally by region 2000-2020

Published by
Matej Mikulic,
Dec 15, 2020
The share of Certificates of Suitability of Monographs of the European Pharmacopoeia (CEPs) has shifted from Europe towards Asia between 2000 and 2018. In 2000, Europe held 59 percent of global CEPs but only 33 percent in 2020. CEPs are proof certificates of an active pharmaceutical ingredient's quality, and are used for drug approvals.

Percentage of valid certificates (CEPs) for active pharmaceutical ingredients quality worldwide from 2000 to 2020, by major region*

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2020

Region

Worldwide

Survey time period

2000 to 2020

Supplementary notes

The source does not provide any information regarding missing percentage points to 100 percent.
* All valid CEPs (Certificates of Suitability of Monographs of the European Pharmacopoeia) in the respective calendar year for the APIs under consideration. Does not include expired or withdrawn CEPs.
** As of April 30, 2020.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

5

Segments

7

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the UKGlobal pharmaceutical industryPharmaceutical industry in the U.S.AstraZenecaNational Health Service (NHS) UK
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu